<DOC>
	<DOCNO>NCT01387256</DOCNO>
	<brief_summary>This double blind , placebo-controlled randomize trial compare safety , efficacy acceptability two medical abortion regimens 63 day since last Menstrual Period ( LMP ) Tunisia Vietnam . The first regimen include 200 mg oral dose mifepristone follow 800 mcg buccal misoprostol . The second regimen include two 800 mcg dos buccal misoprostol three hour apart . All drug administer AT home participant .</brief_summary>
	<brief_title>Comparing Two Regimens Medical Abortion : Mifepristone + Misoprostol Versus Misoprostol Alone</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Gestational age &lt; 63 day since LMP , confirm ultrasound clinical assessment . General good health include absence condition contraindicate use mifepristone misoprostol pregnancy termination . Agrees return followup visit willing provide address and/or telephone number purpose followup . Able consent study participation . Gestational age &gt; 63 day LMP Confirmed suspect ectopic molar pregnancy Contraindications medical abortion include intrauterine device ( IUD ) place ( must remove procedure ) , chronic adrenal failure , concurrent longterm corticosteroid therapy , history allergy mifepristone , misoprostol prostaglandin , hemorrhagic disorder concurrent anticoagulant therapy , inherited porphyry .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>abortion</keyword>
	<keyword>mifepristone</keyword>
	<keyword>misoprostol</keyword>
	<keyword>gestation &gt; 63 day LMP</keyword>
</DOC>